Golden Throat Holdings Group Company Limited (HKG:6896)
3.680
-0.010 (-0.27%)
Apr 2, 2026, 4:08 PM HKT
HKG:6896 Market Cap
HKG:6896 has a market cap or net worth of 2.73 billion as of April 2, 2026. Its market cap has increased by 16.04% in one year.
Market Cap
2.73B
Enterprise Value
2.28B
Revenue
1.05B
Ranking
n/a
PE Ratio
9.76
Stock Price
3.68
Market Cap Chart
Since July 15, 2015, HKG:6896's market cap has decreased from 3.54B to 2.73B, a decrease of -22.88%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.72B | 20.66% |
| Dec 31, 2025 | 2.25B | -5.86% |
| Dec 31, 2024 | 2.40B | -3.28% |
| Dec 29, 2023 | 2.48B | 75.39% |
| Dec 30, 2022 | 1.41B | 20.89% |
| Dec 31, 2021 | 1.17B | 18.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Shineway Pharmaceutical Group | 6.78B |
| Beijing Tong Ren Tang Chinese Medicine Company | 6.35B |
| Edding Genor Group Holdings | 5.36B |
| Hua Medicine (Shanghai) | 3.37B |
| VISEN Pharmaceuticals | 2.71B |
| Jacobson Pharma Corporation | 2.46B |
| JBM (Healthcare) | 2.17B |
| Essex Bio-Technology | 2.04B |